Thomas Lavin - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Thomas Lavin’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Genetics,
- Cybersecurity,
- Android,
- Information Technology (IT),
- Electronics,
- Biotech,
- Internet of Things (IoT),
- Medical Device,
- Software,
- Manufacturing,
- Healthcare,
- Biotechnology,
- Supply Chain Management,
- Genomics,
- Satellite Communication,
- Aerospace,
- Marketing,
- Digital Marketing,
- Nanotechnology,
- Medical,
- SaaS,
- Battery,
- Therapeutics,
- Media and Entertainment,
- Biopharma,
- Security
Social media:
Past investments:
- Paradigm Diagnostics
- Vuv Analytics
- Kateeva
- Vaultive
- Celleration
- Oxyrane UK
- Ikonisys
- NorthSea Therapeutics
- ProterixBio
- Lightwire
- Vorago Technologies
- Ralexar Therapeutics
- Ario Pharma
- ChromaCure
- Resolve Therapeutics
- Cambridge Epigenetix
- Ovizio
- DUST Identity
- BioVex
- BrightVolt
- Seahorse Bioscience
- Svelte Medical Systems
- Morrow Optics
- Akarna Therapeutics
- Escalier Biosciences
- Ventyx Biosciences
- Fuzzy Logix
- PlanetIQ
- Zeotap
- Juventas Therapeutics
- Novadip Biosciences
- Light Sciences Oncology
- Achronix Semiconductor
- BioProcessors
- Dezima Pharma
- TherOx
- TigerConnect
- Ception Therapeutics
- Caringo
- ISORG
- EXTEN Technologies
- FlowCardia
- NeXeption
Investor Profile
Thomas Lavin is a Micro VC, Venture Capital, Private Equity Firm based in New York, United States with a diverse investment portfolio that includes companies such as Paradigm Diagnostics, Vuv Analytics, Kateeva, Vaultive, Celleration, Oxyrane UK, Ikonisys, NorthSea Therapeutics, ProterixBio, Lightwire, Vorago Technologies, Ralexar Therapeutics, Ario Pharma, ChromaCure, Resolve Therapeutics, Cambridge Epigenetix, Ovizio, DUST Identity, BioVex, BrightVolt, Seahorse Bioscience, Svelte Medical Systems, Morrow Optics, Akarna Therapeutics, Escalier Biosciences, Ventyx Biosciences, Fuzzy Logix, PlanetIQ, Zeotap, Juventas Therapeutics, Novadip Biosciences, Light Sciences Oncology, Achronix Semiconductor, BioProcessors, Dezima Pharma, TherOx, TigerConnect, Ception Therapeutics, Caringo, ISORG, EXTEN Technologies, FlowCardia, NeXeption. Over time, Thomas Lavin has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Thomas Lavin is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Cybersecurity, Android, Information Technology (IT), Electronics, Biotech, Internet of Things (IoT), Medical Device, Software, Manufacturing, Healthcare, Biotechnology, Supply Chain Management, Genomics, Satellite Communication, Aerospace, Marketing, Digital Marketing, Nanotechnology, Medical, SaaS, Battery, Therapeutics, Media and Entertainment, Biopharma, Security may find it worthwhile to explore potential connections with Thomas Lavin, as their portfolio suggests a familiarity and interest in this area.
Understanding Thomas Lavin’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
